ONCY
Oncolytics Biotech Inc
0.631$
-1.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -15.8% | -10.5% | -7.7% | -24.3% | -16.8% | -2.4% | +1.4% | -24.6% | -49.6% | +7.6% | -6.0% | |
| – | -15.8% | -12.6% | -8.2% | -25.2% | -17.6% | -2.1% | +2.2% | -25.6% | -51.3% | +9.4% | -5.6% | |
| – | -12.7% | -15.2% | -16.1% | -21.1% | -18.7% | -4.0% | -4.4% | -15.5% | -57.9% | +5.6% | -25.1% | |
| – | -12.7% | -15.2% | -16.1% | -21.1% | -18.7% | -4.0% | -4.4% | -15.5% | -57.9% | +5.6% | -25.1% | |
| – | -97.6% | +580.0% | +1,440.2% | -93.4% | -34.6% | +30.9% | -19.1% | -25.0% | +961.1% | +67.7% | +26.3% | |
| – | -34.1% | +4.7% | +16.8% | +10.5% | -6.6% | -7.0% | +5.1% | +7.6% | -23.8% | +16.8% | +4.1% | |
| – | -57.7% | -3.2% | +49.6% | +24.8% | -12.7% | -13.7% | +13.7% | +16.7% | -20.3% | -11.1% | -3.7% | |
| – | -30.4% | +34.6% | +25.7% | +11.6% | +10.4% | +4.7% | +0.3% | -4.5% | -30.6% | -14.0% | -16.9% | |
| – | -50.5% | -31.2% | +19.1% | +286.8% | -68.3% | -28.3% | +70.9% | +215.6% | -16.6% | -23.5% | +27.0% | |
| – | -5.0% | -16.7% | -20.3% | -50.5% | -33.9% | +8.5% | -6.2% | -98.1% | -3,403.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +5.6% | +2.1% | +1.1% | +1.2% | +3.9% | +5.8% | +7.5% | +11.3% | +6.6% | +4.0% | +6.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.